Track the Cinclus Pharma Holding AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Cinclus Pharma Holding AB (publ) has published 8 insider filings. Market capitalisation: €556.6m. The latest transaction was filed on 8 June 2026 (Purchase). Among the most active insiders: Gösta Hiller. Every trade is free.
8
Insider Decl.
n/a
Thresholds
€53,191
8 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Buys €53,191n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
6,000 shares@ €1.66820.0018% mcap100.0% of flowAktieISINISIN SE0020388577FI:A003X228-1
8 of 8 declarations
Acerca de Cinclus Pharma Holding AB (publ)
Cinclus Pharma Holding AB (publ) es una empresa farmacéutica centrada en el desarrollo de tratamientos para enfermedades autoinmunes e inflamatorias. Cotiza en la Bolsa de Estocolmo (XSTO).